| 1. The Company has only one class of equity share having par value of
Rs. 10 per share. Each holder of equity share is entitle to one vote
per share. In the event of liquidation of the Company, the holder of
the equity share will be entitle to receive remaining assets of the
Company. The distribution will be in proportion to the number of equity
shares held by the share holders.
2. RELATED PARTY DISCLOSURE
Related Party disclosure as required by AS-18, are given below:
I Relationship:
a Subsidiary of the Company Nil
b Associates and Joint Ventures Nil
c Individual having control / Dr. Dinesh S. Patel ( Managing
significant influence Director)
d Key Managerial Personnel Dr. Dinesh S. Patel ( Managing Director)
& Relative thereof
Mrs. Sonal D. Patel ( Managing Director)
e Enterprises over which Nil
(c), (d] & (e) above have
3. As The Company's business activity, in the opinion of the
management, falls within a single primary segment subject to the same
risk and return, the disclosure requirement of Accounting Standard
AS-17 "Segment Reporting" issued by the Institute of Chartered
Accountants of India are not applicable.
4. CONTINGENT LIABILITIES AND COMMITMENTS 31.03.2015 31.03.2014
i Contingent Liabilities
a Claims against the Company/disputes & - -
liabilities
b Guarantee - -
c Letter of Credit - -
ii Commitments
a Estimated amt. of contract remaining to
be executed on capital - -
b Other commitments - -
5. The Company has accumalated losses and its Networth has been
substantially eroded. Furthure the Company has incurrred a net cash
loss during the current year. However the accounts are prepared on
going concern basis.
6. PREVIOUS YEAR FIGURES
Previous year figures are regrouped, rearranged and recast wherever
required to make them comparable with those of year under review.
7. Notes 1 to 31 form an integral part of the financial statements.
HEMO ORGANIC LIMITED (formerly known as Dinesh Allorga Limited)
|